Stanford developed the latest vaccine, which can cover all strains, and the antibody response is 100 times stronger than the existing mRNA vaccine
Scientists at Biohub and Stanford developed a new crown nanoparticle vaccine based on ferritin, Delta-C70-Ferritin-HexaPro (DCFHP).
DCFHP-alum can cover all known new crown variants and can elicit an antibody response 100 times stronger than existing mRNA vaccines. Stable after 14 days storage at 37˚C.
A strong antigenic response can also be elicited in a booster immunization one year after the initial immunization.
DCFHP-alum can generate potent, long-lasting, and broad-spectrum neutralizing antibodies in nonhuman primates.
If it can be confirmed that it can produce equally powerful antibodies in the human body, perhaps the new coronavirus will become history like smallpox.
The funder behind the research is Zuckerberg.
